Dr. Glyn Belcher has over 30 years experience in clinical development and drug safety in the pharmaceutical industry. Dr. Belcher qualified in medicine from Oxford and Cambridge and received his PhD in neuropharmacology from the latter university. After a number of years in hospital internal medicine he joined Schering and worked in clinical research in the UK affiliate before moving to headquarters in Berlin, first as Head of Cardiovascular Clinical Research and later as Head of a New Safety Department covering clinical development activities. Dr. Belcher then became Director of Clinical Drug Safety for Takeda Europe. His most recent full-time position in the industry was as Vice President of Drug Safety and Risk Management for all ex-USA territories of Biogen Idec. Dr. Belcher currently continues to work part-time as consultant safety physician to Biogen Idec and other companies as well undertaking an increasing commitment to teaching and training in the areas of clinical development and pharmacovigilance.